| 注册
首页|期刊导航|中国肺癌杂志|肺癌血清肿瘤标志物的临床意义

肺癌血清肿瘤标志物的临床意义

赵肖 王孟昭

中国肺癌杂志2011,Vol.14Issue(3):286-291,6.
中国肺癌杂志2011,Vol.14Issue(3):286-291,6.DOI:10.3779/j.issn.1009-3419.2011.03.16

肺癌血清肿瘤标志物的临床意义

Clinical Utility of Serum Tumor Markers in Lung Cancer

赵肖 1王孟昭1

作者信息

  • 1. 100730,北京,中国医学科学院,中国协和医科大学,北京协和医院呼吸内科
  • 折叠

摘要

Abstract

Lung cancer shows a tendency of higher incidence and higher mortality in recent years, but the overall 5-year survival rate is less than 15 %.Serum tumor markers oflung cancer play an important role in early diagnosis, determining of pathology types, staging, evaluation of response, and prognosis oflung cancer.In this review, 6 most important markers were reviewed, including neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), cytokeratin l9 fragments (Cyfra 21-1), tissue polypeptide antigen (TPA), squamous cell carcinoma associated antigen (SCC-Ag), carcinoembryonic antigen (CEA).

关键词

肺肿瘤/肿瘤标志物/诊断/治疗

分类

医药卫生

引用本文复制引用

赵肖,王孟昭..肺癌血清肿瘤标志物的临床意义[J].中国肺癌杂志,2011,14(3):286-291,6.

中国肺癌杂志

OA北大核心CSTPCD

1009-3419

访问量0
|
下载量0
段落导航相关论文